ÇÇÇÏ ¾à¹°Àü´Þ ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Ç° À¯Çüº°, »ç¿ë¼ºº°, À¯Åë ä³Îº°, Áö¿ªº° - ½ÃÀå ¿¹Ãø(2024-2032³â)
Subcutaneous Drug Delivery Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type, By Usability, By Distribution Channel, and By Region - Market Forecast, 2024-2032
»óǰÄÚµå : 1552522
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 117 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,853,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,230,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,607,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ÇÇÇÏ ¾à¹°Àü´Þ ±â±â ¼¼°è ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 535¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ÇÇÇÏ ¾à¹°Àü´Þ ±â±â ½ÃÀå¿¡´Â Àν¶¸° Ææ, ÀÚµ¿ ÁÖ»ç±â, ÁÖÀÔ ÆßÇÁ µî ÇÇÇÏ·Î ¾à¹°À» Åõ¿©Çϵµ·Ï ¼³°èµÈ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ÀåÄ¡´Â ¸¸¼º Áúȯ¿¡ ´ëÇÑ ÅëÁ¦µÈ ȯÀÚ Ä£È­ÀûÀÎ ¾à¹°Àü´ÞÀ» ÃËÁøÇÏ¿© º¹¾à ¼øÀÀµµ¿Í Ä¡·á °á°ú¸¦ °³¼±ÇÕ´Ï´Ù.

¼¼°è ÇÇÇÏ ¾à¹°Àü´Þ ±â±â ½ÃÀåÀº ¸î °¡Áö ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÎÇØ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ´ç´¢º´, ·ù¸¶Æ¼½º °üÀý¿° µî ºó¹øÇÑ ¾à¹° Åõ¿©°¡ ÇÊ¿äÇÑ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÇÇÇÏ ¾à¹°Àü´Þ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â±â ¼³°èÀÇ ±â¼úÀû Áøº¸¿Í ÅëÇÕ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ» °®Ãá ½º¸¶Æ® ±â±âÀÇ °³¹ß·Î ȯÀÚµéÀÇ ¼øÀÀµµ¿Í ÆíÀǼºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Á¤È®Çϰí Á¶Àý °¡´ÉÇÑ Åõ¿© ¿ä¹ýÀ» ÇÊ¿ä·Î ÇÏ´Â °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ »õ·Î¿î Æ®·»µåµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçÅà ÀÇ·á¿Í ÀÚ°¡ Åõ¾à¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÇÇÇÏ ¾à¹°Àü´Þ ±â±âÀÇ Ã¤ÅÃÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº ÀåÄ¡ ±â¼úÀÇ Çõ½Å°ú ÇÔ²² ½ÃÀåÀÇ ±Ëµµ¸¦ °è¼Ó Çü¼ºÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇÇÇÏ ¾à¹°Àü´Þ ±â±â ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Á¦Ç° À¯Çüº°·Î´Â ÀÚµ¿ ÁÖ»ç±â°¡ ÇÇÇÏ ¾à¹°Àü´Þ ±â±â ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â »ç¿ëÀÇ ¿ëÀ̼º, ÆíÀǼº, ºó¹øÇÑ ÀÚ°¡ Åõ¾àÀÌ ÇÊ¿äÇÑ ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿¡ ±âÀÎÇÕ´Ï´Ù.

»ç¿ë¼º Ãø¸é¿¡¼­ ÀÏȸ¿ë ±â±â´Â ÆíÀǼº, »ç¿ë ÆíÀǼº, ȯÀÚ ¹× ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿¡°Ô ¾îÇÊÇÒ ¼ö ÀÖ´Â °¨¿° À§Çè °¨¼Ò·Î ÀÎÇØ ½ÃÀå¿¡¼­ ¾ÐµµÀûÀÎ ¿ìÀ§¸¦ Á¡Çϰí ÀÖ½À´Ï´Ù.

À¯Åë ä³Î¿¡¼­ º´¿ø ¾à±¹Àº Àß ±¸ÃàµÈ ÀÎÇÁ¶ó¿Í Á¤±âÀûÀÎ Åõ¾àÀÌ ÇÊ¿äÇÑ ¸¸¼º Áúȯ ȯÀÚ°¡ ¸¹±â ¶§¹®¿¡ ¿©ÀüÈ÷ ¾ÐµµÀûÀÎ À§Ä¡¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ´Â ¹Ý¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ÇÇÇÏ ¾à¹°Àü´Þ ±â±â ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ÇÇÇÏ ¾à¹°Àü´Þ ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦6Àå ¼¼°èÀÇ ÇÇÇÏ ¾à¹°Àü´Þ ±â±â ½ÃÀå : »ç¿ë¼ºº°

Á¦7Àå ¼¼°èÀÇ ÇÇÇÏ ¾à¹°Àü´Þ ±â±â ½ÃÀå : À¯Åë ä³Îº°

Á¦8Àå ¼¼°èÀÇ ÇÇÇÏ ¾à¹°Àü´Þ ±â±â ½ÃÀå : Áö¿ªº°

Á¦9Àå °æÀï »óȲ

Á¦10Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global subcutaneous drug delivery devices market size is expected to reach USD 53.50 billion by 2032, according to a new study by Polaris Market Research. The report "Subcutaneous Drug Delivery Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type (Auto-Injectors, Pre-filled Syringes, Pen Injectors, Wearable Injectors, and Needle Free Injectors), By Usability, By Distribution Channel, and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The subcutaneous drug delivery devices market encompasses products designed for the administration of medication under the skin, such as insulin pens, auto-injectors, and infusion pumps. These devices facilitate controlled, patient-friendly drug delivery for chronic conditions, improving adherence and therapeutic outcomes.

The global subcutaneous drug delivery devices market is experiencing robust growth driven by several key factors. The increasing prevalence of chronic diseases such as diabetes and rheumatoid arthritis, which require frequent medication administration, is significantly boosting demand for subcutaneous delivery solutions. Additionally, technological advancements in device design and the development of smart devices with integrated monitoring systems are enhancing patient compliance and convenience.

The emerging trend toward personalized medicine, which necessitates precise and adjustable dosing regimens, is also contributing to the market expansion. Moreover, the growing emphasis on home healthcare and self-administration of medications is further fueling the adoption of subcutaneous drug delivery devices. These factors, coupled with innovations in device technology, are expected to continue shaping the market's trajectory.

Subcutaneous Drug Delivery Devices Market Report Highlights

Based on product type, the auto-injectors segment dominates the subcutaneous drug delivery devices market, driven by their ease of use, convenience, and the growing prevalence of chronic diseases that require frequent self-administration.

By usability, the disposable devices segment holds the dominant position in the market due to their convenience, ease of use, and reduced risk of infection, which appeals to patients and healthcare providers.

In terms of distribution channel, the hospital pharmacies segment remains the dominating segment due to their established infrastructure and the high volume of chronic disease patients requiring regular medication.

North America dominates the market, whereas Asia Pacific is expected to witness the highest growth rate during the forecast period.

Key players in the subcutaneous drug delivery devices market include AbbVie, Medtronic, Novo Nordisk, Eli Lilly, Becton, Dickinson and Company (BD), Johnson & Johnson, Insulet Corporation, Ypsomed, Sanofi, Roche, Bayer, Terumo Corporation, Pfizer, 3M, and Dexcom.

Polaris Market Research has segmented the subcutaneous drug delivery devices market report on the basis of product type, usability, distribution channel, and region.

Subcutaneous Drug Delivery Devices - Product Type Outlook (Revenue - USD Billion, 2019-2032)

Subcutaneous Drug Delivery Devices - Usability Outlook (Revenue - USD Billion, 2019-2032)

Subcutaneous Drug Delivery Devices - Distribution Channel Outlook (Revenue - USD Billion, 2019-2032)

Subcutaneous Drug Delivery Devices - Regional Outlook (Revenue - USD Billion, 2019-2032)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Subcutaneous Drug Delivery Devices Market Insights

5. Global Subcutaneous Drug Delivery Devices Market, by Product Type

6. Global Subcutaneous Drug Delivery Devices Market, by Usability

7. Global Subcutaneous Drug Delivery Devices Market, by Distribution Channel

8. Global Subcutaneous Drug Delivery Devices Market, by Geography

9. Competitive Landscape

10. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â